Your browser does not support JavaScript or it may be disabled!
 India As It Happens
Rediff Labs will showcase innovative products that rediff is working on behind the scenes.
News   |   Images
Get Realtime News
on your webpage

About 867 results for "astrazeneca"

AstraZeneca insists Celgene deal about strategy, not cash

AstraZeneca, Innate Pharma ink co-development & commercialisat...

AstraZeneca and its global biologics research and development arm, MedImmune, have signed a co-development and commercialization agreement with Innate Pharma SA to accelerate and broaden the development of Innate Pharma's proprietary anti-NKG2A ... PharmaBiz, 7 hours ago
AstraZeneca and Innate Pharma team up cancer Seeking Alpha, 20 hours ago
Celgene and MedImmune team up in blood cancer Seeking Alpha, 23 hours ago

724 images for astrazeneca

American Banking News, 5 hours ago
Yahoo! News, 19 hours ago
Reuters India, 18 hours ago
Reuters, 18 hours ago
Reuters, 1 day ago
Reuters, 1 day ago
Pharmafocus, 3 days ago
Pharmaceutical Business Review, 3 days ago, 2 days ago
Pharmafocus, 5 days ago

Bina Technologies and AstraZeneca Announce Collaborative Agreement for Global Deployment of Bina's Genomic Management Solution

AstraZeneca will use Bina's Genomic Management Solution to accelerate the incorporation of genomic data into its drug development programs across three main therapeutic areas April 21, 2015 07:00 AM Eastern Daylight Time PLEASANTON, Calif. & ...
 Fierce Biotech IT11 hours ago Bina Technologies And AstraZeneca PLC Announce Collaborative Agreement For Global Deployment Of Genomic Management Solution  BioSpace3 days ago AstraZeneca and Bina collaborate to deploy genomic management solution in R&D  FirstWord Pharma3 days ago AstraZeneca : Bina Technologies and AstraZeneca Announce Collaborative Agreement for Global Deployment of Bina's Genomic Management Solution  4 Traders4 days ago

AstraZeneca profits climb, unveils French tie-up with Innate Pharma

Revenues meanwhile climbed by one percent at constant currencies to $6.057 billion, aided by a strong performance in China. LONDON: British drugmaker AstraZeneca on Friday posted rising quarterly profits and unveiled a partnership with French biotech firm ...
 Economic Times22 hours ago China sales lift Astra Zeneca revenue  Hong Kong Standard22 hours ago AFP - Britain-pharma-earnings-business-AstraZeneca  Namibia Press Agency23 hours ago
Pharmaceutical Business Review

FDA News Roundup: AstraZeneca, Pfizer, AbbVie, Actavis, And More

By Anna Rose Welch , associate editor What FDA decisions did you miss this week? Orphan Drug Designations AstraZeneca's MEK inhibitor selumetinib was named an orphan drug for uveal melanoma. The drug, which inhibits the MEK pathway and ...
 Pharmaceutical Online9 hours ago AstraZeneca -Selumetinib granted Orphan Drug Designation by US FDA for treatment of uveal melanoma  Pharmacy Choice5 days ago AstraZeneca's tremelimumab receives FDA approval to treat mesothelioma  CPhI.cn5 days ago AstraZeneca receives orphan drug designation from FDA for uveal melanoma drug  Individual.com4 days ago

AstraZeneca plc Has a Rocky First-Quarter: Here's What You Need to Know

Astra's earnings and revenue are nevertheless down significantly compared to a year ago, reflecting the loss of exclusivity for top-selling drugs like acid reflux medication On a nonadjusted basis, for instance, revenue dropped by 6% and earnings ...
 Motley Fool17 hours ago AstraZeneca plc (ADR) (AZN) Q1 Profits Decline Amid Patent Expiry Of Top Drugs  Bidness Etc21 hours ago

Result of AGM

ASTRAZENECA PLC - ANNUAL GENERAL MEETING 2015 Results of Annual General Meeting held on 24 April 2015 AstraZeneca PLC announced the results of the voting at its Annual General Meeting today. As proposed in the Notice of AGM, all Resolutions were ...
 NASDAQ OMX18 hours ago AstraZeneca PLC Result of AGM  ADVFN UK18 hours ago AstraZeneca PLC 1st Quarter Results  ADVFN UK1 day ago

SmarTrend Watching for Potential Rebound in Shares of AstraZeneca After 1.83% Loss

AstraZeneca (NYSE:AZN) traded in a range yesterday that spanned from a low of $71.05 to a high of $72.43. Yesterday, the shares fell 1.8%, which took the trading range below the 3-day low of $72.13 on volume of 1.9 million shares. Often times ...
 Individual.com13 hours ago

AstraZeneca's (AZN) CEO Pascal Soriot on Q1 2015 Results - Earnings Call Transcript

Pascal Soriot Hello, everyone. This is Pascal Soriot, CEO of AstraZeneca. Welcome to the Q1 2015 Results Conference Call for Investors and Analysts. Our slides are posted online for you to follow via telephone or webcast. Im joined today by Marc ...
 Seeking Alpha15 hours ago AstraZeneca sales retreat in its effort to achieve huge growth by 2023  FiercePharma20 hours ago

Shares of AstraZeneca Under Pressure, Down 2.4%

AstraZeneca (NYSE:AZN) is a company whose shares are active, trading 1.9% lower to $71.73. The Dow Jones Industrial Average is now trading fractionally higher to 18,074 and the S&P is trading 0.2% higher
 Individual.com18 hours ago

Why Are Shire PLC And Hikma Pharmaceuticals Plc Wiping The Floor With GlaxoSmithKline plc?

Eyes have been turned towards AstraZeneca and its Q1 update this week, but a look at the rest of our FTSE 100 pharmaceuticals firms shows something perhaps surprising. GlaxoSmithKline (LSE: GSK)(NYSE: GSK.US) has long been the benchmark against ...
 Yahoo! UK and Ireland21 hours ago
Prev | Next
Personalize your Realtimeclose [x]
Add content to your personalized tab - My News
Add upto 6 topics of your interest:
for eg.2g Scam , World
Personalize the tabs display. ( You can add or remove the tabs )
AlertsGet updates on latest news & your favourite topics right in your inbox.Set an Alert|Manage your Alerts


Realtime News

on your Webpage

Add Widget >Get your members hooked!
Related Queries - astrazeneca
Get updated on latest news & your favorite topics right in your inbox!
More     Less